1-11 of 11
Russ Kuker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 trial of abbreviated fixed-duration (Default 4 Cycles) linvoseltamab immuno-consolidation to deepen responses post newly diagnosed multiple myeloma combination therapy for minimal residual disease positivity (the IMMUNOPLANT Study)

Free
Dickran Kazandjian, Benjamin Diamond, James Hoffman, Abhishek Pandey, David Coffey, Marcella Kaddoura, Brian Walker, David Lessen, Caterine Diaz, Stephanie Mompoint, Sindy Gutierrez, Jennifer Chapman, Yi Zhou, Mike Georgiou, Russ Kuker, Kellye Koubek, Andrew Kowalski, Leslie Gallardo, Stephanie Fernandes, Fiorela Flores, Rabia Bukhari, Sunwoo Han, Michelle Armogan, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 248.
https://doi.org/10.1182/blood-2025-248
Published: 2025
Journal Articles

A phase 2 trial of 89Zr-DFO-daratumumab for CD38-targeted imaging of multiple myeloma (the iMMunoPET study)

Free
Ola Landgren, Russ Kuker, Ryan Reddy, Alanna Vossen, Jayashree Motwani, Ben Goldenson, Benjamin Diamond, Abhishek Pandey, James Hoffman, David Coffey, Marcella Kaddoura, Mike Georgiou, Brian Walker, Rabia Bukhari, Caterine Diaz, Stephanie Mompoint, Sindy Gutierrez, Kellye Koubek, Stephanie Fernandes, Michelle Armogan, Dickran Kazandjian, Gary Ulaner
Journal: Blood
Blood (2025) 146 (Supplement 1): 4052.
https://doi.org/10.1182/blood-2025-4052
Published: 2025
Journal Articles

Feasibility and preliminary efficacy of a Mediterranean diet and home-based exercise intervention during chemotherapy for lymphoma survivors: The life-l study

Free
Melissa Lopez-Pentecost, Tracy Crane, Akina Natori, Juan Alderuccio, Alvaro Alencar, Michele Stanchina, Georgios Pongas, Asaad Trabolsi, Jonathan Schatz, Ashley Rose, David Lessen, Joseph Rosenblatt, Izidore S. Lossos, Juan Carlos Ramos, Russ Kuker, Craig Moskowitz
Journal: Blood
Blood (2025) 146 (Supplement 1): 4547.
https://doi.org/10.1182/blood-2025-4547
Published: 2025
Journal Articles

Association of Body Composition Factors and Toxicity in Patients with Advanced Stage Hodgkin Lymphoma Receiving BV-AVD

Free
Michele D. Stanchina, Russ Kuker, Sunwoo Han, Fei Yang, Mark K Polar, Jillian Lorayne Lykon, Tracy Crane, Melissa Lopez-Pentecost, Craig H. Moskowitz, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2024-203734
Published: 2024
Journal Articles

Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Free
Dickran Kazandjian, Kellye Koubek, Andrew Kowalski, Stephanie Mompoint, Rabia Bukhari, Maila Wilson, Jeremy Deni, Sydney Jackson, Yahirini Rodriguez-Martinez, Justin Llano, Michelle Armogan, Stephanie Fernandes, Maurizio Affer, Sana Chaudhry, Tulasigeri M Totiger, Catalina Amador, Melinda Boone, Jennifer Rose Chapman-Fredricks, Mike Georgiou, Russ Kuker, Katie Thoren, Yi Zhou, David G. Coffey, Marcella Kaddoura, Francesco Maura, Benjamin Diamond, James Edward Hoffman, Justin Taylor, Ola Landgren
Journal: Blood
Blood (2024) 144 (Supplement 1): 7049.
https://doi.org/10.1182/blood-2024-193966
Published: 2024
Journal Articles

Epcoritamab with R-CHOP Overcomes Poor Risk Features of High Total Metabolic Tumor Volume in High-Risk Large B-Cell Lymphoma

Free
Juan Pablo Alderuccio, Russ Kuker, Mark K Polar, Fei Yang, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1622.
https://doi.org/10.1182/blood-2024-209334
Published: 2024
Journal Articles

Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma

Free
Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H. Schatz, Russ Kuker, David Sicre, Georgios Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Michele D. Stanchina, Asaad Trabolsi, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 337.
https://doi.org/10.1182/blood-2024-199093
Published: 2024
Journal Articles

Limited Duration Loncastuximab Tesirine Induces a High Rate of Complete Responses in Patients with Relapsed/Refractory Marginal Zone Lymphoma - Report of First Planned Interim Futility Analysis of a Multicenter Phase II Study

Free
Izidore S. Lossos, Geoffrey Shouse, Alvaro J Alencar, Safia Sawleh, David S. Lessen, Craig H. Moskowitz, Jennifer Rose Chapman-Fredricks, Isildinha M. Reis, Russ Kuker, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 3032.
https://doi.org/10.1182/blood-2024-200205
Published: 2024
Journal Articles

PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma

Free
Juan Pablo Alderuccio, Michele D. Stanchina, Jean L. Koff, Isildinha M. Reis, Eduardo Edelman Saul, Melissa C. Larson, Dai Chihara, Wei Zhao, Thomas M. Habermann, Peter Martin, Loretta J. Nastoupil, Jennifer R. Chapman-Fredricks, Andrew L. Feldman, Brian K. Link, Brad S. Kahl, Jonathon B. Cohen, Mark K Polar, Rafael Henneman Sassi, Craig H. Moskowitz, Jonathan W. Friedberg, James R. Cerhan, Russ Kuker, Christopher R. Flowers, Izidore S. Lossos
Journal: Blood
Blood (2023) 142 (Supplement 1): 5134.
https://doi.org/10.1182/blood-2023-179478
Published: 2023
Journal Articles

Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Free
Dickran Kazandjian, Justin Taylor, Kellye Koubek, Rabia Bukhari, Maila Wilson, Isabella Schiwy, Yahirini Rodriguez-Martinez, Justin Llano, Stephanie Fernandes, Michelle Armogan, Maurizio Affer, Sana Chaudhry, Tulasigeri M Totiger, Catalina Amador, Melinda Boone, Jennifer R. Chapman-Fredricks, Mike Georgiou, Russ Kuker, Katie Thoren, Yi Zhou, Benjamin Diamond, James E. Hoffman, Ola Landgren
Journal: Blood
Blood (2023) 142 (Supplement 1): 6740.
https://doi.org/10.1182/blood-2023-180939
Published: 2023
Journal Articles

Limited Duration Loncastuximab Tesirine with Rituximab Induces High Complete Metabolic Response Rate in High-Risk Relapsed/Refractory Follicular Lymphoma - a Phase 2 Study

Free
Juan Pablo Alderuccio, Alvaro J. Alencar, Jonathan H. Schatz, Russ Kuker, Georgio Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Nathalie Padron, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 984.
https://doi.org/10.1182/blood-2023-178825
Published: 2023